Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic pros...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 33 1 58 33 50 00
Fax: 33 1 58 33 50 01
Address:
70 rue Balard, Paris, France
